Previously, both our group and other investigators have studied the association between PSA level in the blood and the long-term risk of being diagnosed with any stage of prostate cancer, but did not specifically address whether these findings were applicable to diagnosis of advanced tumors [1,14-16]. The gene discussed is KLK3; the disease is Familial prostate cancer.